Patent US5656590A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5656590A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of anorexia and related states

Assignee: Amylin Pharmaceuticals LLC
•
Filing: 1992-05-23
•
Granted: 1997-08-12
•
Expires: 2012-05-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method for treatment of a patient suffering from anorexia or a related condition by administering amylin or an analogue thereof and/or to the patient in an amount sufficient to increase amylin and/or insulin levels in the plasma of the patient.

Inventors

  • 👤 Timothy J. Rink
  • 👤 Andrew A. Young

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:58
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/28; A61P; A61P3/00; A61P3/06; A61P3/08

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 38 words
A method for treatment of a patient suffering from anorexia comprising the step of: administering amylin or an analogue thereof to said patient in an amount sufficient to increase the amylin level in the plasma of said patient.
Claim 2
Independent Claim 38 words
A method for treatment of a patient suffering from anorexia comprising the step of: administering amylin or an analogue thereof to said patient in an amount sufficient to increase the amylin level in the plasma of said patient.
Claim 3
Independent Claim 42 words
A method for treatment of a cachectic patient or a patient undergoing parenteral nutrition comprising the step of: administering amylin or an analogue thereof to said patient in an amount sufficient to increase the amylin level in the plasma of said patient.
Claim 4
Independent Claim 42 words
A method for treatment of a cachectic patient or a patient undergoing parenteral nutrition comprising the step of: administering amylin or an analogue thereof to said patient in an amount sufficient to increase the amylin level in the plasma of said patient.
Claim 5
Dependent Claim 34 words
The method of claim 1 wherein said amount of amylin or amylin analogue administered is sufficient to increase the anabolic effect of plasma amylin within the liver, and thereby increase glycogen levels by glycogenesis.
Claim 6
Dependent Claim 27 words
The method of claim 1 wherein said amylin is administered in an amount sufficient to enhance mobilization of lactate from muscle to form fat in the liver.
Claim 7
Dependent Claim 26 words
The method of claim 1 or 2 wherein said amylin or amylin analogue is provided in an amount sufficient to increase adipose tissue in said patient.
Claim 8
Dependent Claim 25 words
The method of claim 1 or 2 further comprising administering insulin to said patient an amount sufficient to increase the insulin level in said patient.
Claim 9
Dependent Claim 26 words
The method of claim 6 wherein said amylin and/or said insulin are provided in an amount or amounts sufficient to increase adipose tissue in said patient.
Claim 10
Independent Claim 36 words
A method for treating a patient deficient in adipose tissue comprising administering amylin or an amylin analogue alone or in conjunction with insulin in an amount and ratio sufficient to increase adipose tissue in said patient.
Claim 11
Independent Claim 36 words
A method for treating a patient deficient in adipose tissue comprising administering amylin or an amylin analogue alone or in conjunction with insulin in an amount and ratio sufficient to increase adipose tissue in said patient.
Claim 12
Independent Claim 32 words
A method for treatment of a patient suffering from anorexia comprising administering amylin or an analogue thereof to said patient in an amount sufficient to increase the body weight of said patient.
Claim 13
Independent Claim 32 words
A method for treatment of a patient suffering from anorexia comprising administering amylin or an analogue thereof to said patient in an amount sufficient to increase the body weight of said patient.
Claim 14
Independent Claim 38 words
A method for treatment of a cachectic patient or a patient undergoing parenteral nutrition comprising administering to said patient an amount of amylin or an amylin analogue sufficient to reduce the amount of weight loss in said patient.
Claim 15
Independent Claim 38 words
A method for treatment of a cachectic patient or a patient undergoing parenteral nutrition comprising administering to said patient an amount of amylin or an amylin analogue sufficient to reduce the amount of weight loss in said patient.
Claim 16
Dependent Claim 34 words
The method of claim 9 wherein said amount of amylin or amylin analog administered is sufficient to increase the anabolic effect of plasma amylin within the liver, and thereby increase glycogen levels by glycogenesis.
Claim 17
Dependent Claim 27 words
The method of claim 9 wherein said amylin is administered in an amount sufficient to enhance mobilization of lactate from muscle to form fat in the liver.
Claim 18
Dependent Claim 26 words
The method of claim 9 or 10 wherein said amylin or amylin analog is provided in an amount sufficient to increase adipose tissue in said patient.
Claim 19
Dependent Claim 28 words
The method of claim 9 or 10 further comprising administering to said patient an amount of insulin sufficient to increase the amount of said insulin in said patient.
Claim 20
Dependent Claim 26 words
The method of claim 14 wherein said amylin and/or said insulin are provided in an amount or amounts sufficient to increase adipose tissue in said patient.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-08-11 2001-02-10 2001-08-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-08-11 2005-02-10 2005-08-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-08-11 2009-02-10 2009-08-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag